InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: A deleted message

Thursday, 11/16/2017 10:05:12 PM

Thursday, November 16, 2017 10:05:12 PM

Post# of 44784
You are right Eichking. It is pointless. Many beliebers here like Tweens in love with their idols. Don't care what they do, eyes glossed over.

Who cares if they've promised partners for years.

Who cares they do a useless promotion and give big bonuses.

Who cares that our stock price is lower than we were 7+ years ago.

Who cares that they waste countless cash going to these useless shows

Who cares they are transparent as a brick wall

Who cares that our competition doesn't sit still

Who cares that with every passing year we keep the twins, it will cost more to can them.

Who cares that they've diluted 3 times this year, and still could be.

Who cares that a vast majority of management has zero pharma background.

Who cares that they can't get Japanese fast track started after 2 years with the go ahead.

Who cares we delayed progression of trials 2 years to focus on manufacturing side, only for it to sit mostly idle.

Who cares that nepotism ran rampant in 3 of our management team coming from Elbit.

Who cares ...endless in reality.

The list is endless when it comes to management. Throw in how we have only phase 1 data results in reality for all but ARS. Sound good three phase 3's, but the chances for them carrying over from the phase 1 results, are historically low. This thing is far from guaranteed. There is a reason that big pharma is NOT going to do a deal with Pluristem on their terms, it's because the numbers aren't there yet to support the results.

It cracks me up when someone mentions Scott Gottlieb and tries to insinuate he is talking about Pluristem. It's absurd to say the least.

ARS will hopefully be our saviour. It's out of the twins hand so there's a good shot there. I think if that fails to come to fruition in the next year, it will be lights out. I/C results if amazing, could also do the trick.

Repetitive I am yes, as long as there's beliebers around and our share price remains in the toilet, I will continue to repeat. And because your beloved one continues to pump for the sake of their employer, is also my reason. OPA!!! Oh yes, until we get real management as well!!!

But like you, I will continue to have a vested interest in this stock on the long side. Wish I spent the last 7 years on the short side that's for sure. Until they either make it or collapse, I will be there. Product has great potential, management stinks. Belieb it or not. LMBO!!!